1. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials;Griffin;Expert Opin Biol Ther,2013
2. IMS Institute for Healthcare Informatics http://www.quotidianosanita.it/allegati/allegato1501906.pdf
3. IMS Institute for Healthcare Informatics https://morningconsult.com/wp-content/uploads/2016/04/IMS-Institute-US-Drug-Spending-2015.pdf
4. European Medicines Agency http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/01/WC500180219.pdf
5. Patent expiry dates for biologicals: 2017 update;GaBI Journal Editor;GaBI J,2018